HSG Holding Ltd

Holdings History for Lyell Immunopharma, Inc. - Common Stock par value $0.0001 per share (LYEL)

Symbol: LYEL on Nasdaq
Investment type: Equity - Shares of Stock
Class: Common Stock par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024	0.43%		$1.74M	3.05M			$0.57	Q4 2024
9/30/2024	0.13%		$3.41M	3.05M			$1.12	Q3 2024
6/30/2024	0.2%		$5M	3.05M			$1.64	Q2 2024
3/31/2024	0.69%		$7.43M	3.05M			$2.44	Q1 2024
12/31/2023	0.74%		$6.4M	3.05M			$2.10	Q4 2023
9/30/2023	0.48%		$4.48M	3.05M			$1.47	Q3 2023
6/30/2023	1.11%		$9.69M	3.05M			$3.18	Q2 2023
3/31/2023	0.76%		$7.19M	3.05M			$2.36	Q1 2023
12/31/2022	1.07%		$10.6M	3.05M			$3.47	Q4 2022
9/30/2022	2.4%		$22.3M	3.05M			$7.33	Q3 2022
6/30/2022	1.83%		$19.9M	3.05M			$6.52	Q2 2022
3/31/2022	1.92%		$15.4M	3.05M			$5.05	Q1 2022
12/31/2021	2.11%		$23.6M	3.05M			$7.74	Q4 2021
9/30/2021	4.05%	+0.63%	$45.1M	3.05M	+609,199	+25%	$14.80	Q3 2021
6/30/2021	2.76%	+2.94%	$39.6M	2.44M	+2,436,798	NEW	$16.24	Q2 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.